Metabolic syndrome in women with and without stress urinary incontinence

  • Rejane Lis Menegaz StröherEmail author
  • Marair Gracio Ferreira Sartori
  • Claudia Cristina Takano
  • Maita Poli de Araújo
  • Manoel João Batista Castelo Girão
Original Article



Metabolic syndrome (MS) is a disease of multifactorial etiology characterized by increased waist circumference, elevated triglyceride levels, decreased HDL cholesterol levels, high blood pressure and hyperglycemia. The objective of this study was to compare the frequency of MS in patients with and without stress urinary incontinence (SUI).


The components of MS were evaluated in 85 women with SUI seen at the Urogynecology and Vaginal Surgery Sector of the Gynecology Department of Universidade Federal de São Paulo (UNIFESP-EPM) and in 108 women without SUI seen at the General Gynecology Clinic of the Gynecology Department of UNIFESP-EPM.


The MS diagnosis was more prevalent in patients with SUI, with the frequency according to the International Diabetes Federation criteria being 69.4% in the case group with SUI and 38% in the control group, whereas according to the National Cholesterol Education Program Adult Treatment Panel III recommendations, MS was frequent in 64.7% of the cases and 25% of the controls. Each MS component was evaluated, and the body mass index, weight and waist circumference were significantly higher in the case group (with SUI) compared with the control group (p < 0.001). The women in the case group showed an average HDL cholesterol value statistically lower and triglyceride and glycemia values statistically higher than the women in the control group (p < 0.001 and p = 0.005).


MS frequency was higher in patients with SUI, which shows a possible association between these two conditions.


Metabolic syndrome Obesity Stress urinary incontinence 


Compliance with ethical standards

Conflicts of interest



  1. 1.
    Danforth KN, Townsend MK, Lifford K, Curhan GC, Resnick NM, Grodstein F. Risk factors for urinary incontinence among middle-aged women. Am J Obstet Gynecol. 2006;194:339–45.CrossRefGoogle Scholar
  2. 2.
    Bump RC, Mattiasson AM, BØ K, Brubaker LP, DeLancey JO, Klarsskov P, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175(1):10–7.CrossRefGoogle Scholar
  3. 3.
    Haylen BT, De Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4–20.Google Scholar
  4. 4.
    Reynolds WS, Dmochowski RR, Penson DF. Epidemiology of stress urinary incontinence in women. Curr Urol Rep. 2011;12:370–6.CrossRefGoogle Scholar
  5. 5.
    Hunskaar S, Arnold EP, Burgio K, Diokno AC, Herzog AR, Mallett VT. Epidemiology and natural history of urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2000;11(5):301–19.CrossRefGoogle Scholar
  6. 6.
    Walker GJA, Gunasekera P. Pelvic organ prolapse and incontinence in developing countries: review of prevalence and risk factors. Int Urogynecol J. 2011;22:127–35.CrossRefGoogle Scholar
  7. 7.
    Hunskaar S. Systematic review of overweight and obesity. Neurourol Urodyn. 2008;27:749–57.CrossRefGoogle Scholar
  8. 8.
    Kim YH, Kim JJ, Kim SM, Choi Y, Jeon MJ. Association between metabolic syndrome and pelvic floor dysfunction in middle-aged to older Korean women. Am J Obstet Gynecol. 2011;205:71–8.Google Scholar
  9. 9.
    Gorbachinsky I, Akpinar H, Assimos DG. Metabolic syndrome and urologic diseases. Rev Urol. 2010;12(4):157–80.Google Scholar
  10. 10.
    Dwyer PL, Lee ETC, Hay DM. Obesity and urinary incontinence in women. BJOG: 95(1) 91-96.
  11. 11.
    Townsend MK, Curhan GC, Resnick NM, Grodstein F. BMI, waist circumference, and incident urinary incontinence in older women. Obesity. 2008;16:881–6.CrossRefGoogle Scholar
  12. 12.
    Lawrence JM, Lukacz ES, Nager CW, Luber KM. Pelvic floor disorders, diabetes, and obesity in women. Diabetes Care. 2007;30:2536–41.CrossRefGoogle Scholar
  13. 13.
    Luber KM. The definition, prevalence, and risk factors for stress urinary incontinence. Rev Urol. 2004;6 suppl 3.Google Scholar
  14. 14.
    Jackson SL, Scholes D, Boyko EJ, Abraham L, Fihn SD. Urinary incontinence and diabetes in postmenopausal women. Diabetes Care. 2005;28:1730–8.CrossRefGoogle Scholar
  15. 15.
    Lifford KL, Curban GC, Hu FB, Barbieri RL, Grodstein F. Type 2 diabetes mellitus and risk developing urinary incontinence. Am Geriatr Soc. 2005;53:1851–7.CrossRefGoogle Scholar
  16. 16.
    Brown JS, Vittinghoff E, Lin F, Nyberg LM, Kusek JW, Kanaya AM. Prevalence and risk factors for urinary incontinence in women with type 2 diabetes and impaired fasting glucose. Diabetes Care. 2006;29:1307–12.CrossRefGoogle Scholar
  17. 17.
    Tai HC, Chung SD, Ho CH, et al. Metabolic syndrome components worsen lower urinary tract symptoms in women with type 2 diabetes. J Clin Endocrinol Metab. 2010;95:1143–50.CrossRefGoogle Scholar
  18. 18.
    Maserejien NN, Giovannucci EL, McVary KT, McGrother C, McKinlay JB. Dietary macronutrient and energy intake and urinary incontinence in women. Am J Epidemiol. 2010;171:1116–25.CrossRefGoogle Scholar
  19. 19.
    Dalosso H, Matthews R, McGrother C, Donaldson M. Diet as a risk factor for the development of stress urinary incontinence: a longitudinal study in women. Eur J Clin Nutr. 2004;58:920–6.CrossRefGoogle Scholar
  20. 20.
    Brown JS, Wing R, Connor EB, Nyberg LM, Kusek JW, Orchard TJ, et al. Lifestyle intervention is associated with lower prevalence of urinary incontinence. Diabetes Care. 2006;29:385–90.CrossRefGoogle Scholar
  21. 21.
    Subak LL, Whitcomb E, Shen H, et al. Weight loss: a novel and effective treatment for urinary incontinence. J Urol. 2005;174:190–5.CrossRefGoogle Scholar
  22. 22.
    Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23(4):322–30.CrossRefGoogle Scholar
  23. 23.
    Tamanini JTN, Dambros M, D’Ancona CA, Palma PCR, Rodrigues Netto N Jr. Validation of the "International Consultation on Incontinence Questionnaire-short form" (ICIQ-SF) for Portuguese. Rev Saúde Pública. 2004;38(3):438–44.CrossRefGoogle Scholar
  24. 24.
    The Portuguese validation of the International Consultation on Incontinence Questionnaire—Vaginal Symptoms (ICIQ-VS) for Brazilian women with pelvic organ prolapse. Int Urogynecol J. 2008;19 Number 10.Google Scholar
  25. 25.
    VI Diretrizes Brasileiras de Hipertensão. Arq Bras Cardiol 2010; 95(1 suppl 1) 1–51.Google Scholar
  26. 26.
    Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high cholesterol in adults (adult treatment panel III)- final report. Circulation. 2002;106(25):3143–421.CrossRefGoogle Scholar
  27. 27.
    International Diabetes Federation: The IDF consensus world-wide definition of the metabolic syndrome. April 14, 2005:
  28. 28.
    Otunctemur A, Dursun M, Ozbek E, Sahin S, Besiroglu H, Koklu I, et al. Impact of metabolic syndrome on stress urinary incontinence in pre- and postmenopausal women. Int Urol Nephrol. 2014;46(8):1501–5.CrossRefGoogle Scholar
  29. 29.
    Hannestad YS, Rortveit G, Sandvik H, Hunskaar S. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of incontinence in the county of Nord-Trøndelag. J Clin Epidemiol. 2000;53(11):1150–7.CrossRefGoogle Scholar

Copyright information

© The International Urogynecological Association 2019

Authors and Affiliations

  • Rejane Lis Menegaz Ströher
    • 1
    Email author
  • Marair Gracio Ferreira Sartori
    • 1
  • Claudia Cristina Takano
    • 1
  • Maita Poli de Araújo
    • 1
  • Manoel João Batista Castelo Girão
    • 1
  1. 1.Universidade Federal de Sao PauloSão PauloBrazil

Personalised recommendations